Cambridge Nutritional Sciences PLC Change of website (6561M)

TIDMCNSL

RNS Number : 6561M

Cambridge Nutritional Sciences PLC

15 September 2023

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

Change of website

Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms that following the successful Name Change announced today ( RNS: 5260M ) the Company's website containing the information required by AIM Rule 26 has changed to: www.cnsplc.com .

The Company's new X (formerly Twitter) handle is @CNS_PLC.

Contacts:

 
 Cambridge Nutritional Sciences plc                                            www.cnsplc.com 
 Jag Grewal, Chief Executive Officer                                          via Walbrook PR 
 
 
 Cavendish Capital Markets Limited                                         Tel: 020 7220 0500 
 Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) 
 Nigel Birks / Harriet Ward (ECM) 
 
 
 Walbrook PR Limited                                 Tel: 020 7933 8780 or CNS@walbrookpr.com 
 Paul McManus / Lianne Applegarth                          Mob: 07980 541 893 / 07584 391 303 
 Sam Allen                                                                 Mob: 07502 558 258

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPUMABUPWGWA

(END) Dow Jones Newswires

September 15, 2023 10:00 ET (14:00 GMT)

Omega Diagnostics (LSE:ODX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024